The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 31, 2013
Filed:
Jul. 03, 2008
Josef Bencsik, Longmont, CO (US);
James F. Blake, Longmont, CO (US);
James M. Graham, Longmont, CO (US);
Martin F. Hentemann, Lafayette, CO (US);
Nicholas C. Kallan, Boulder, CO (US);
Ian S. Mitchell, Lafayette, CO (US);
Stephen T. Schlachter, Boulder, CO (US);
Keith L. Spencer, Lyons, CO (US);
Dengming Xiao, Longmont, CO (US);
Rui Xu, Longmont, CO (US);
Mike Welch, Westminster, CO (US);
Jun Liang, Palo Alto, CA (US);
Brian S. Safina, Redwood City, CA (US);
Josef Bencsik, Longmont, CO (US);
James F. Blake, Longmont, CO (US);
James M. Graham, Longmont, CO (US);
Martin F. Hentemann, Lafayette, CO (US);
Nicholas C. Kallan, Boulder, CO (US);
Ian S. Mitchell, Lafayette, CO (US);
Stephen T. Schlachter, Boulder, CO (US);
Keith L. Spencer, Lyons, CO (US);
Dengming Xiao, Longmont, CO (US);
Rui Xu, Longmont, CO (US);
Mike Welch, Westminster, CO (US);
Jun Liang, Palo Alto, CA (US);
Brian S. Safina, Redwood City, CA (US);
Array Biopharma, Inc., Boulder, CO (US);
Genentech, Inc., South San Francisco, CA (US);
Abstract
The present invention provides compounds of Formula (I), including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.